Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Red blood cell membrane-derived microparticles and their use for the treatment of lung disease

Red blood cell membrane-derived microparticles and their use for the treatment of lung disease

US Patent 10596197 · Granted Mar 24, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Red blood cell membrane-derived microparticles and their use for the treatment o2018
Red blood cell membrane-derived microparticles and their use for the treatment o2018
Red blood cell membrane-derived microparticles and their use for the treatment o2018
Selective targeting agents for mitochondria2016
Selective targeting agents for mitochondria2015
Radioprotective agents2014
Use of targeted nitroxide agents in mitigating or treating radiation injury2014
Degradation of nanomaterials2013
Selective targeting agents for mitochondria2010
Selective targeting agents for mitochondria2009